Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gizem Kocabas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Contact Dermatitis|August 22, 2024
Results of patch testing propolis in the European baseline series: A 4-year retrospective studyGizem Kocabas, Norbertus A Ipenburg, Anton de Groot, et al.
Contact Dermatitis|December 26, 2023
Results of patch testing 2-hydroxyethyl methacrylate (HEMA) in the European baseline series: A 4-year retrospective studyGizem Kocabas, Iemke M Steunebrink, Anton de Groot, et al.
Contact Dermatitis|May 7, 2024
2-Hydroxyethyl methacrylate (HEMA) 1% versus 2Gizem Kocabas, Norbertus A Ipenburg, Anton C de Groot, et al.
Haematologica|December 20, 2024
Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidenceRajani P Brandsen, Roselie M H Diederen, Gizem Kocabas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Contact Dermatitis|August 22, 2024
Results of patch testing propolis in the European baseline series: A 4-year retrospective studyGizem Kocabas, Norbertus A Ipenburg, Anton de Groot, et al.
Contact Dermatitis|December 26, 2023
Results of patch testing 2-hydroxyethyl methacrylate (HEMA) in the European baseline series: A 4-year retrospective studyGizem Kocabas, Iemke M Steunebrink, Anton de Groot, et al.
Contact Dermatitis|May 7, 2024
2-Hydroxyethyl methacrylate (HEMA) 1% versus 2Gizem Kocabas, Norbertus A Ipenburg, Anton C de Groot, et al.
Haematologica|December 20, 2024
Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidenceRajani P Brandsen, Roselie M H Diederen, Gizem Kocabas, et al.
Pageof 1